Top Companies in Sweden Pharmaceutical Market
This report lists the top Sweden Pharmaceutical companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Sweden Pharmaceutical industry.
-
Amgen
-
Pfizer
-
Novartis
-
Orifarm Group
-
Merck
*Disclaimer: Top companies sorted in no particular order
Sweden PharmaceuticalMarket Concentration
Sweden PharmaceuticalCompany List
-
AbbVie Inc.
-
Merck & Co., Inc.
-
Amgen Inc.
-
Pfizer Inc.
-
GlaxoSmithKline plc
-
F. Hoffmann-La Roche AG
-
AstraZeneca plc
-
Eli Lilly and Company
-
Novartis International AG
-
Sanofi S.A.
-
Swedish Orphan Biovitrum AB
-
InDex Pharmaceuticals Holding AB
-
Medartuum AB
-
Life Medical Sweden AB
Specific to Sweden Pharmaceutical Market
Competitive Landscape Report Includes
Company Profiles (includes Global Level Overview, Market Level Overview, Core Business Segments, Financials, Headcount, Key Information, Market Rank, Market Share, Products and Services, and Analysis of Recent Developments). Key Strategic Moves, Market Share Analysis, Company Landscape, and List of Companies.
Sweden Pharmaceutical Market Companies Summary
The pharmaceutical market in Sweden has been significantly impacted by the COVID-19 pandemic, which has led to increased pressure on supply chains and procurement of essential medical supplies. This has resulted in a notable increase in product launches for pharmaceutical drugs, contributing to the growth of the market. The pandemic has also led to an increase in the sale of over-the-counter drugs, particularly for the management of various diseases. Despite the challenges, the pharmaceutical industry in Sweden has experienced significant growth due to the pandemic. The growth of the pharmaceutical market in Sweden is also attributed to the rising geriatric population and the increasing incidence of chronic diseases. The demand for pharmaceutical drugs is higher in the aging population, which is more susceptible to chronic diseases. Additionally, the high burden of chronic and lifestyle disorders within the country is driving the demand for pharmaceutical drugs. On the other hand, the stringent regulatory scenario is a major factor restraining the market growth. Despite these challenges, several companies are making acquisitions and joint ventures to consolidate their positions in the market. Key market players are also engaged in product launches, contributing to the growth of the market.
Explore MoreSweden Pharmaceutical Companies - Table of Contents
-
1. COMPETITIVE LANDSCAPE & COMPANY PROFILES
-
1.1 Company Profile
-
1.1.1 AbbVie Inc.
-
1.1.2 Merck & Co., Inc.
-
1.1.3 Amgen Inc.
-
1.1.4 Pfizer Inc.
-
1.1.5 GlaxoSmithKline plc
-
1.1.6 F. Hoffmann-La Roche AG
-
1.1.7 AstraZeneca plc
-
1.1.8 Eli Lilly and Company
-
1.1.9 Novartis International AG
-
1.1.10 Sanofi S.A.
-
1.1.11 Swedish Orphan Biovitrum AB
-
1.1.12 InDex Pharmaceuticals Holding AB
-
1.1.13 Medartuum AB
-
1.1.14 Life Medical Sweden AB
-
-
Sweden Pharmaceutical Companies FAQs
Who are the key players in Sweden Pharmaceutical Market?
Amgen Inc., Pfizer Inc., Novartis International AG, Orifarm Group A/S and Merck & Co., Inc. are the major companies operating in the Sweden Pharmaceutical Market.